REGN · Categories · Form 4
REGN - SEC Form 4 insider transactions
Regeneron Pharmaceuticals Inc. (REGN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for REGN
- SEC Form 4 filed by Ryan Arthur F4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Ryan Arthur F sold $78,550 worth of shares (100 units at $785.50), decreasing direct ownership by 0.56% to 17,703 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Zoghbi Huda Y exercised 1,638 shares at a strike of $376.69 and sold $1,279,812 worth of shares (1,638 units at $781.33) (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- SVP Controller Pitofsky Jason sold $1,585,058 worth of shares (2,036 units at $778.52) and exercised 1,000 shares at a strike of $492.00, decreasing direct ownership by 20% to 4,272 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Ryan Arthur F sold $77,853 worth of shares (100 units at $778.53), decreasing direct ownership by 0.56% to 17,803 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Bassler Bonnie L exercised 1,500 shares at a strike of $374.12 and sold $1,200,000 worth of shares (1,500 units at $800.00) (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Zoghbi Huda Y was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Thompson Craig B. was granted 155 shares, increasing direct ownership by 25% to 775 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Sing George L was granted 155 shares, increasing direct ownership by 0.50% to 31,007 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Guarini Kathryn was granted 155 shares, increasing direct ownership by 35% to 603 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Schenkein David P was granted 155 shares, increasing direct ownership by 35% to 603 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Goldstein Joseph L was granted 155 shares, increasing direct ownership by 2% to 6,703 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Ryan Arthur F was granted 155 shares, increasing direct ownership by 0.87% to 17,903 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Coles N Anthony was granted 155 shares, increasing direct ownership by 10% to 1,714 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Brown Michael S was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Bassler Bonnie L was granted 155 shares, increasing direct ownership by 10% to 1,703 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Poon Christine A was granted 155 shares, increasing direct ownership by 3% to 5,219 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Bd. Co-Chair, President & CSO Yancopoulos George converted options into 28,570 shares and covered exercise/tax liability with 28,570 shares (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Bd. Co-Chair, President & CEO Schleifer Leonard S converted options into 28,570 shares and covered exercise/tax liability with 28,570 shares (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Sing George L exercised 9,212 shares at a strike of $520.01 and covered exercise/tax liability with 6,188 shares, increasing direct ownership by 11% to 30,852 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP & General Mgr, Industrial Van Plew Daniel P covered exercise/tax liability with 2,552 shares, decreasing direct ownership by 11% to 21,673 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research Murphy Andrew J covered exercise/tax liability with 4,229 shares, decreasing direct ownership by 8% to 47,833 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Commercial Mccourt Marion covered exercise/tax liability with 1,021 shares, decreasing direct ownership by 7% to 14,349 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Bd. Co-Chair, President & CSO Yancopoulos George exercised 146,815 shares at a strike of $555.67 and covered exercise/tax liability with 131,874 shares, increasing direct ownership by 5% to 310,460 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Bd. Co-Chair, President & CEO Schleifer Leonard S covered exercise/tax liability with 155,145 shares and exercised 172,723 shares at a strike of $555.67, increasing direct ownership by 9% to 214,523 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- VP Controller Pitofsky Jason covered exercise/tax liability with 989 shares and was granted 2,064 shares, increasing direct ownership by 25% to 5,308 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP & General Mgr, Industrial Van Plew Daniel P was granted 3,715 shares and covered exercise/tax liability with 1,906 shares, increasing direct ownership by 8% to 24,225 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research Murphy Andrew J was granted 3,715 shares and covered exercise/tax liability with 1,699 shares, increasing direct ownership by 4% to 52,062 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Commercial Mccourt Marion was granted 2,476 shares and covered exercise/tax liability with 1,336 shares, increasing direct ownership by 8% to 15,370 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP General Counsel and Secret Larosa Joseph J covered exercise/tax liability with 1,396 shares and was granted 2,476 shares, increasing direct ownership by 4% to 29,517 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Finance CFO Fenimore Christopher R. covered exercise/tax liability with 992 shares and was granted 3,027 shares, increasing direct ownership by 13% to 18,300 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP General Counsel and Secret Larosa Joseph J exercised 14,450 shares at a strike of $555.67 and covered exercise/tax liability with 12,686 shares, increasing direct ownership by 8% to 22,839 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Bassler Bonnie L sold $570,000 worth of shares (760 units at $750.00) and exercised 760 shares at a strike of $371.40 (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- VP Controller Pitofsky Jason sold $280,766 worth of shares (431 units at $651.43), decreasing direct ownership by 9% to 4,233 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Poon Christine A exercised 9,212 shares at a strike of $520.01 and sold $4,252,745 worth of shares (6,500 units at $654.27), increasing direct ownership by 115% to 5,064 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research Murphy Andrew J exercised 35,000 shares at a strike of $555.67, covered exercise/tax liability with 32,490 shares and gifted 1,538 shares, increasing direct ownership by 2% to 50,046 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Schenkein David P was granted 166 shares, increasing direct ownership by 59% to 448 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Thompson Craig B. was granted 166 shares, increasing direct ownership by 37% to 620 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Coles N Anthony was granted 166 shares, increasing direct ownership by 12% to 1,559 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Zoghbi Huda Y was granted 166 shares, increasing direct ownership by 12% to 1,548 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Ryan Arthur F was granted 166 shares, increasing direct ownership by 0.94% to 17,748 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Poon Christine A transferred by will 14 shares) and was granted 166 shares, increasing direct ownership by 8% to 2,352 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Guarini Kathryn was granted 166 shares, increasing direct ownership by 59% to 448 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Goldstein Joseph L was granted 166 shares, increasing direct ownership by 3% to 6,548 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Brown Michael S was granted 166 shares, increasing direct ownership by 12% to 1,548 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Bassler Bonnie L was granted 166 shares, increasing direct ownership by 12% to 1,548 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- Director Sing George L exercised 3,338 shares at a strike of $413.33, covered exercise/tax liability with 1,948 shares and was granted 166 shares, increasing direct ownership by 6% to 27,828 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP & General Mgr, Industrial Van Plew Daniel P covered exercise/tax liability with 969 shares, decreasing direct ownership by 3% to 34,792 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research and Development Stahl Neil covered exercise/tax liability with 304 shares, decreasing direct ownership by 0.62% to 48,829 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- VP Controller Pitofsky Jason covered exercise/tax liability with 298 shares, decreasing direct ownership by 6% to 4,664 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research Murphy Andrew J covered exercise/tax liability with 1,054 shares, decreasing direct ownership by 2% to 49,074 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Commercial Mccourt Marion covered exercise/tax liability with 759 shares, decreasing direct ownership by 5% to 14,230 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP General Counsel and Secret Larosa Joseph J covered exercise/tax liability with 702 shares, decreasing direct ownership by 2% to 30,075 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- SVP Finance & CFO Fenimore Christopher R. covered exercise/tax liability with 491 shares, decreasing direct ownership by 3% to 16,265 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- VP Controller Pitofsky Jason was granted 907 shares, covered exercise/tax liability with 149 shares and received a gift of 179 shares, increasing direct ownership by 18% to 4,962 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- SVP Finance & CFO Fenimore Christopher R. was granted 2,591 shares and covered exercise/tax liability with 1,140 shares, increasing direct ownership by 9% to 16,756 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research and Development Stahl Neil covered exercise/tax liability with 466 shares, decreasing direct ownership by 0.94% to 49,133 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP & General Mgr, Industrial Van Plew Daniel P was granted 3,499 shares and covered exercise/tax liability with 492 shares, increasing direct ownership by 9% to 35,761 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Research Murphy Andrew J was granted 3,499 shares and covered exercise/tax liability with 492 shares, increasing direct ownership by 6% to 50,128 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)
- EVP Commercial Mccourt Marion was granted 2,332 shares and covered exercise/tax liability with 274 shares, increasing direct ownership by 16% to 14,989 units (SEC Form 4)4 - REGENERON PHARMACEUTICALS, INC. (0000872589) (Issuer)